ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
Ovarian Neoplasms
About this trial
This is an interventional treatment trial for Ovarian Neoplasms focused on measuring Ovarian cancer, Ovarian neoplasms, epithelium
Eligibility Criteria
Inclusion Criteria:- Must have evidence of ovarian cancer measurable by computed tomography (CT) scan or by CA125 blood levels- No radiation therapy in last 4 weeks- No chemotherapy in last 24 weeks - No immunotherapy in last 4 weeks- Good response after previous treatment with carboplatin or cisplatin and then the ovarian cancer got worse again after at least 6 months- Additional criteria determined at screening visit Exclusion Criteria:- Having had more than one treatment regimen with carboplatin or cisplatin- Prior treatment with other epothilones (e.g. ixabepilone)- Use of any investigational drug in the last 4 weeks- Previous radiation to the whole pelvis- Symptomatic brain tumors requiring radiation to the brain - Active infection- Pregnant or breast feeding- Additional criteria determined at screening visit
Sites / Locations
Arms of the Study
Arm 1
Experimental
Arm 1